Welcome to IRL

Integrative Research Laboratories Sweden AB (IRL) is a Swedish privately held drug discovery and development company providing novel treatments for disorders of the brain.

IRL is pursuing small molecule programmes targeting core disabilities in dementias, attention disorders and Parkinson’s disease using its unique systems pharmacology discovery approach, the Integrative Screening Process (ISP), to find new treatment solutions.